Hemroid 500 mg Capsule

Uses of Hemroid: - Piles - Varicose veins Peripheral circulatory disorders, Chronic Venous Insufficiency, Venous Ulcer, Glaucoma, Hemorrhoids, Diabetic Retinopathy, Diabetic Angiopathy Hypersensitivity. Pregnancy and lactation.

Vaso Protective

Calcium dobesilate acts selectively on the capillary walls regulating their physiological functions of resistance and permeability. It lowers blood viscosity and restores normal blood flow. This action is beneficial in all cases of capillary fragility due to metabolic disturbances (constitutional or acquired), and surgical stress or induced by certain medicines.

How to use Calcium dobesilate: Take this medicine in the dose and duration as advised by your doctor. Do not chew, crush or break it. Calcium dobesilate is to be taken with food. Adult Dose: Oral Peripheral circulatory disorders Adult: 0.5-1 g daily in divided doses.

Hypersensitivity. Pregnancy and lactation.

Common - Allergic reaction Nausea, diarrhoea, skin rash, fever, headache and vertigo

The safety of Calcium Dobesilate during pregnancy and lactation has not been established. As it is not known whether calcium dobesilate crosses the placental barrier in humans, the drug should be administered during pregnancy only if the benefit to the mother outweighs the potential risk to the fetus. Avoid breastfeeding while using this medicine.

Precaution: Severe renal impairment. In case of skin rash, treatment should be stopped.

The clinical signs of a possible over dosage are not known.

Store in a cool and dry place, away from light. Keep out of the reach of children.

Vaso Protective

Calcium dobesilate acts selectively on the capillary walls regulating their physiological functions of resistance and permeability. It lowers blood viscosity and restores normal blood flow. This action is beneficial in all cases of capillary fragility due to metabolic disturbances (constitutional or acquired), and surgical stress or induced by certain medicines.

Studies in pregnant women or animals are not available. As it is not known whether calcium dobesilate crosses the placental barrier in humans, the drug should only be administered if it was estimated that the anticipated therapeutic benefit outweigh the potential risk to the fetus. Calcium dobesilate enters the maternal milk in very low quantities (0.µ4g/ml after intake of 3×500mg). As a precaution either the treatment or the breast-feeding should be stopped.

Related Medicines

Save Medicine to Collection

Hemroid 500 mg

Create New Collection